-
ASCO 2025: XOFIGO® (radium-223 dichloride) Combination Data Showcases Clinical Benefits in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases
28 May 2025 12:29 GMT
… with valuable insights into the benefits of combining XOFIGO with … known radiographic progression free survival benefit. We are encouraged by … Injection [Prescribing Information]. Whippany, NJ: Bayer HealthCare Pharmaceuticals, December 2019.
Choudhury A …
-
‘Promising’ new data could change treatment landscape for some rare diseases
16 Sep 2025 19:36 GMT
… modulator, revealed several cardiometabolic benefits for patients with hypercortisolism.
… determine if testosterone has added benefits.”
Menopausal HT and tirzepatide … Nordisk. Jones reports advising for Bayer Healthcare, Besins Healthcare and Simple …
-
Advancing antiviral therapeutics for immunocompromised populations
15 Sep 2025 08:43 GMT
… thousands of patients worldwide have benefitted from reduced risk for severe … , Jacques spent 15 years at Bayer Healthcare and seven years at AstraZeneca.
-
The Benefits of Sustaining High Factor VIII Levels in People With Hemophilia A
04 Mar 2025 03:23 GMT
… levels has demonstrated considerable clinical benefit.2 Such maintenance requires … was the lack of perceived benefit from treatment. Because prophylaxis … Information.pdf.
Kovaltry. Prescribing information. Bayer Healthcare; 2022. Accessed November 27, 2024 …
-
#WorldDenseBreastDay launches September 24, 2025
12 Sep 2025 15:07 GMT
… laws,” added Pushkin.
“To fully benefit from appropriate screening, women must … educational grants and donations from Bayer Healthcare, Myriad Genetics, Hologic, Volpara Health …
-
Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study.
13 Jan 2025 11:03 GMT
Alkaline phosphatase (ALP) declines and pain responses can occur during radium-223 (223Ra) treatment, but their association with treatment outcomes is unclear.
For patients with metastatic castration-resistant prostate cancer treated with 223Ra in the …
-
Nonprescription NSAIDs in Osteoarthritis: Clinical Insights on Naproxen Sodium for OA Pain Relief
08 Sep 2025 15:45 GMT
… be carefully balanced against their benefits—particularly in older adults or … adherence.
REFERENCES
Aleve®. Product information. Bayer HealthCare; 2021. Accessed May 21, 2025 …
-
CHARM Therapeutics Appoints Dr Erkut Bahceci as Chief Medical Officer
08 Sep 2025 06:00 GMT
… at Bristol-Myers Squibb and Bayer HealthCare. Erkut earned his Doctor of … clinical development to deliver meaningful benefit for patients with AML.” ENDS …
-
Tivozanib Shows Benefits in Long-Term Survival for Relapsed/Refractory Renal Cell Carcinoma
10 May 2024 17:28 GMT
… improvements compared with sorafenib (Nexavar; Bayer Healthcare) in this patient population.1 … experience a long-term survival benefit from tivozanib over sorafenib.”1 …
-
Contrast Media/Contrast Agent Market to Undertake Incredible Growth 2022- 2028 | Bayer HealthCare, Bracco Imaging S.p.A
28 Oct 2022 09:26 GMT
… :
Lantheus Medical Imaging, GE Healthcare, Bayer HealthCare, Bracco Imaging S.p.A … and competitive landscape structure.
☑ It benefits in creating an awareness of …
About
© 1995-2025